In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters
- PMID: 2073118
- PMCID: PMC172033
- DOI: 10.1128/AAC.34.11.2256
In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters
Abstract
Among 28,000 isolates of the family Enterobacteriaceae and nonfermenters isolated at multiple medical centers, 1,084 (4%) were resistant to cefoperazone (MIC, greater than or equal to 64 micrograms/ml) and 1,711 (6%) exhibited cefoperazone MICs of 2 to 32 micrograms/ml. Ninety-six percent of these 2,795 isolates produced beta-lactamase, as determined by the nitrocefin test. Sulbactam alone (8 micrograms/ml) was inactive against 99.6% of the isolates other than Acinetobacter calcoaceticus and Pseudomonas cepacia. Sulbactam enhanced the activity of cefoperazone against 56% of the isolates of the family Enterobacteriaceae and 44% of the nonfermenters. In the presence of sulbactam concentrations of less than or equal to 8 micrograms/ml, 65% of the cefoperazone-resistant isolates had reductions in cefoperazone MICs of greater than or equal to 2 log2 dilution steps and were susceptible to less than or equal to 32 micrograms/ml. Antagonism was not observed.
Similar articles
-
Comparative in vitro activity of cefoperazone and various combinations of cefoperazone/sulbactam.Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):45-9. doi: 10.1016/0732-8893(90)90053-x. Diagn Microbiol Infect Dis. 1990. PMID: 2331849
-
The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.Am J Clin Pathol. 1985 Oct;84(4):496-504. doi: 10.1093/ajcp/84.4.496. Am J Clin Pathol. 1985. PMID: 2994461
-
Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.J Clin Microbiol. 1988 Jan;26(1):13-7. doi: 10.1128/jcm.26.1.13-17.1988. J Clin Microbiol. 1988. PMID: 3343304 Free PMC article.
-
beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.Clin Infect Dis. 1997 Mar;24(3):494-7. doi: 10.1093/clinids/24.3.494. Clin Infect Dis. 1997. PMID: 9114205 Review.
-
Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?Infect Genet Evol. 2021 Mar;88:104707. doi: 10.1016/j.meegid.2021.104707. Epub 2021 Jan 5. Infect Genet Evol. 2021. PMID: 33418147 Review.
Cited by
-
Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains.Folia Microbiol (Praha). 2001;46(2):151-5. doi: 10.1007/BF02873595. Folia Microbiol (Praha). 2001. PMID: 11501404
-
β-Lactams and β-Lactamase Inhibitors: An Overview.Cold Spring Harb Perspect Med. 2016 Aug 1;6(8):a025247. doi: 10.1101/cshperspect.a025247. Cold Spring Harb Perspect Med. 2016. PMID: 27329032 Free PMC article. Review.
-
Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii.Braz J Microbiol. 2015 Oct-Dec;46(4):1119-24. doi: 10.1590/S1517-838246420140101. Braz J Microbiol. 2015. PMID: 26691470 Free PMC article.
-
Stenotrophomonas maltophilia bacteremia in adult patients with hematological diseases: clinical characteristics and risk factors for 28-day mortality.Microbiol Spectr. 2025 Jan 7;13(1):e0101124. doi: 10.1128/spectrum.01011-24. Epub 2024 Nov 29. Microbiol Spectr. 2025. PMID: 39611832 Free PMC article.
-
In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.Antimicrob Agents Chemother. 1996 Jun;40(6):1412-8. doi: 10.1128/AAC.40.6.1412. Antimicrob Agents Chemother. 1996. PMID: 8726011 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources